Decoy receptor 3 suppresses B cell functions and has a negative correlation with disease activity in rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical and Experimental Rheumatology

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  PMID 25084482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis

  2013cited by this paper
• Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis?

  2013cited by this paper
• Similar clinical outcomes in rheumatoid arthritis with more versus less expensive treatment strategies. Observational data from two rheumatology clinics.

  2013cited by this paper
• High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new‐onset rheumatoid arthritis

  2013cited by this paper
• Treat-to-target in rheumatoid arthritis: clinical and pharmacoeconomic considerations. Introduction.

  2012cited by this paper
• Overexpression of decoy receptor 3 in synovial tissues of inflammatory arthritis.

  2012cited by this paper
• Decoy Receptor 3 Suppresses TLR2-Mediated B Cell Activation by Targeting NF-κB

  2012cited by this paper
• Decoy Receptor 3 Attenuates Collagen-induced Arthritis by Modulating T Cell Activation and B Cell Expansion

  2011cited by this paper
• The Roles of B Cells and Their Interactions with Fibroblast-Like Synoviocytes in the Pathogenesis of Rheumatoid Arthritis

  2011cited by this paper
• Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.

  2011cited by this paper
• DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts.

  2011cited by this paper
• Decoy receptor 3 is highly expressed in patients with rheumatoid arthritis

  2010cited by this paper
• Down regulation of Fc and complement receptors on B cells in rheumatoid arthritis.

  2010cited by this paper
• Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis

  2010cited by this paper
• B cells in the pathogenesis and treatment of rheumatoid arthritis

  2010cited by this paper
• B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy

  2010cited by this paper
• Decoy receptor 3 ameliorates experimental autoimmune encephalomyelitis by directly counteracting local inflammation and downregulating Th17 cells.

  2009cited by this paper
• Erythrocyte Sedimentation Rate, C-Reactive Protein, or Rheumatoid Factor Are Normal at Presentation in 35%–45% of Patients with Rheumatoid Arthritis Seen Between 1980 and 2004: Analyses from Finland and the United States

  2009cited by this paper
• Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies

  2009cited by this paper
• Targeting the LIGHT-HVEM pathway.

  2009cited by this paper
• Role of TL1A in the Pathogenesis of Rheumatoid Arthritis1

  2009cited by this paper
• Functional characterisation of decoy receptor 3 in Crohn’s disease

  2008cited by this paper
• Role of B cells in systemic lupus erythematosus and rheumatoid arthritis.

  2008cited by this paper
• DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus.

  2008cited by this paper
• Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3).

  2008cited by this paper
• Decoy Receptor 3 Expression in AsPC-1 Human Pancreatic Adenocarcinoma Cells via the Phosphatidylinositol 3-Kinase-, Akt-, and NF-κB-Dependent Pathway1

  2008cited by this paper
• Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis.

  2008cited by this paper
• Auto-antibodies and autoreactive T-cells in rheumatoid arthritis

  2007cited by this paper
• Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.

  2007cited by this paper
• The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.

  2006cited by this paper
• Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.

  2006cited by this paper
• Autoantibodies in rheumatoid arthritis: a review.

  2006cited by this paper
• Apoptosis resistance in ulcerative colitis: High expression of decoy receptors by lamina propria T cells

  2006cited by this paper
• The Glycosaminoglycan-Binding Domain of Decoy Receptor 3 Is Essential for Induction of Monocyte Adhesion1

  2006cited by this paper
• Up-regulated transforming growth factor beta-inducible gene h3 in rheumatoid arthritis mediates adhesion and migration of synoviocytes through alpha v beta3 integrin: Regulation by cytokines.

  2006cited by this paper
• Synovial tissue inflammation in early and late osteoarthritis

  2005cited by this paper
• Attenuation of Th1 Response in Decoy Receptor 3 Transgenic Mice1

  2005cited by this paper
• Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

  2004cited by this paper
• Modulation of macrophage differentiation and activation by decoy receptor 3

  2004cited by this paper
• Soluble Decoy Receptor 3 Induces Angiogenesis by Neutralization of TL1A, a Cytokine Belonging to Tumor Necrosis Factor Superfamily and Exhibiting Angiostatic Action

  2004cited by this paper
• B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience

  2003cited by this paper
• Roles of B cells in rheumatoid arthritis

  2003cited by this paper
• Modulation of Dendritic Cell Differentiation and Maturation by Decoy Receptor 31

  2002cited by this paper
• B cells regulate autoimmunity by provision of IL-10

  2002cited by this paper
• Modulation of T-cell responses to alloantigens by TR6/DcR3.

  2001cited by this paper
• Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis.

  2001cited by this paper
• T Cell Activation in Rheumatoid Synovium Is B Cell Dependent1

  2001cited by this paper
• B cells in rheumatoid arthritis

  2000cited by this paper
• Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas.

  2000cited by this paper
• Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster.

  2000cited by this paper
• A Newly Identified Member of Tumor Necrosis Factor Receptor Superfamily (TR6) Suppresses LIGHT-mediated Apoptosis*

  1999cited by this paper
• Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

  1998cited by this paper
• Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium.

  1997cited by this paper
• Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissue.

  1996cited by this paper
• Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts.

  1996cited by this paper
• Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.

  1996cited by this paper
• Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

  1995cited by this paper
• The clinical and research significance of the erythrocyte sedimentation rate.

  1994cited by this paper
• Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis.

  1989cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Antigen-specific interaction between T and B cells

  1985cited by this paper
• Radiological Assessment of Osteo-Arthrosis

  1957cited by this paper

• Immuno‐epigenomic analysis identifies attenuated interferon responses in naïve CD4 T cells of adolescents with peanut and multi‐food allergy

  2022cites this paper
• Allergy and Immunotoxicology in Occupational Health - The Next Step

  2020cites this paper
• Clinical Evaluation of Plasma Decoy Receptor 3 Levels in Silicosis

  2020cites this paper
• Role of TGFβ3-Smads-Sp1 axis in DcR3-mediated immune escape of hepatocellular carcinoma

  2019cites this paper
• DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin

  2017cites this paper
• Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions

  2017cites this paper